Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 6, 2005

Circulation. 2005
Published online before print June 6, 2005, doi: 10.1161/CIRCULATIONAHA.104.519132
A more recent version of this article appeared on June 14, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/23/3135    most recent
CIRCULATIONAHA.104.519132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shepherd, J.
Right arrow Articles by Nicklin, M. J.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shepherd, J.
Right arrow Articles by Nicklin, M. J.H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Other Vascular biology

Submitted on June 26, 2004
Revised on January 19, 2005
Accepted on March 2, 2005

Elastic-Vessel Arteritis in Interleukin-1 Receptor Antagonist-Deficient Mice Involves Effector Th1 Cells and Requires Interleukin-1 Receptor

Joanna Shepherd PhD and Martin J.H. Nicklin PhD*

From the Division of Genomic Medicine, University of Sheffield, Sheffield, United Kingdom.

* To whom correspondence should be addressed. E-mail: m.nicklin{at}shef.ac.uk.

Background--In mice that lack interleukin-1 receptor antagonist (IL-1ra), transmural inflammation of the elastic arteries develops at sites of turbulent flow. We described late histopathology previously. Here, we investigate the cellular events in nonlethal arteritis at the aortic root and compare them with Takayasu’s arteritis and giant cell arteritis.

Methods and Results--IL-1ra-deficient mice were inbred from the original stocks and from BALB/c backcrosses. Disease was ascertained histologically and immunohistologically postmortem at the aortic root. Onset appeared to be stochastic and was not detectably age dependent; in our local Sf3 strain, the half-time of onset was {approx}52 days. Loss of the type I IL-1 receptor suppressed the arteritis. Microvascular activation, as determined by absence of strong E-selectin expression, was absent from preaffected vessels. In mildly affected cases, infiltration was adventitial. In severely affected animals, infiltrates appeared to be active in destroying elastin, but resynthesis of disorganized elastin occurred at closely adjacent sites. Infiltrates consisted predominantly of macrophages but were rich in CD4+-interferon-{gamma}+ cells, which are likely to represent Th1 cells. Dendritic cells accumulated in lesional areas.

Conclusions--The arteritic phenotype of IL-1ra deficiency is mediated by the interleukin-1 receptor and involves effector Th1 cells. The destructive pattern and many of the cellular features of arteritis in IL-1ra-deficient mice resemble the human elastic-vessel arteritides, for which these mice may be a useful animal model.


Key words: immunohistochemistry • immunology • inflammation • interleukins • receptors




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. He, D.-C. Guo, W. Sun, C. L. Papke, S. Duraisamy, A. L. Estrera, H. J. Safi, C. Ahn, L. Maximilian Buja, F. C. Arnett, et al.
Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 922 - 929.
[Abstract] [Full Text] [PDF]